Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;41(1):312-317.
doi: 10.12669/pjms.41.1.10568.

Survival after venoarterial extracorporeal membrane oxygenation for acute high-risk Pulmonary Embolism: A meta-analysis of comparative studies

Xiaoying Yang  1 , Min Xiang  2 , Lifang Wu  3 , Meng He  4 , Hongyan Zhu  5
Affiliations
Review

Survival after venoarterial extracorporeal membrane oxygenation for acute high-risk Pulmonary Embolism: A meta-analysis of comparative studies

Xiaoying Yang et al. Pak J Med Sci. 2025 Jan.

Abstract

Objective: The survival benefit of venoarterial Extracorporeal Membrane Oxygenation (ECMO) for the management of acute high-risk pulmonary embolism (PE) remains unclear. This meta-analysis combines data from comparative studies to assess the risk of mortality after ECMO vs standard care in the management of acute high-risk PE.

Methods: Databases of PubMed, CENTRAL, Scopus, Web of Science, and Embase were searched from 01st January 2000 to 24th March 2023 for comparative studies with at least 10 patients/group comparing ECMO vs standard treatment. PRISMA guidelines were followed for this review. We extracted mortality data and combined it to obtain the outcome as risk ratios (RR) with 95% confidence intervals (CI) in a random-effects model.

Results: Ten studies were included. Meta-analysis showed that the risk of early mortality was not significantly different between ECMO and non-ECMO groups (RR: 0.97 95% CI: 0.78, 1.19 I2=73%). No change in significance was noted on subgroup analysis based on study location, sample size, cardiac arrest, systemic thrombolysis, and surgical embolectomy.

Conclusion: Limited evidence derived from mostly retrospective studies riddled with selection bias suggests that ECMO may not offer additional survival benefits in high-risk PE.

Keywords: Critical care; Extracorporeal Membrane Oxygenation; Mortality; Thromboembolism.

PubMed Disclaimer

Figures

Fig.1
Fig.1
Study flowchart.
Fig.2
Fig.2
Meta-analysis of mortality between ECMO and non-ECMO groups.
See this image and copyright information in PMC

References

    1. Prabhu W, Soukas PA. Pulmonary Embolism in 2017: Increasing Options for Increasing Incidence. R I Med J (2013) 2017;100(5):27–32. - PubMed
    1. Ozen Y, Ugur M, Ozbek IC, Yalcinkaya E. Early-term outcomes of the pulmonary embolism response team. Pak J Med Sci. 2022;38:2182–2187. doi: 10.12669/pjms.38.8.6541. - PMC - PubMed
    1. Meneveau N. Therapy for acute high-risk pulmonary embolism: thrombolytic therapy and embolectomy. Curr Opin Cardiol. 2010;25:560–567. doi: 10.1097/HCO.0B013E32833F02C5. - PubMed
    1. Gupta R, Ammari Z, Dasa O, Ruzieh M, Burlen JJ, Shunnar KM, et al. Long-term mortality after massive, submassive, and low-risk pulmonary embolism. Vasc Med. 2020;25:141–149. doi: 10.1177/1358863X19886374. - PubMed
    1. Tapson VF. Treatment of pulmonary embolism: anticoagulation, thrombolytic therapy, and complications of therapy. Crit Care Clin. 2011;27:825–839. doi: 10.1016/J.CCC.2011.08.002. - PubMed

LinkOut - more resources